The International Oncology Conference 2012 will focus on translational advances in the treatment of cancer. Leading doctors and researchers will discuss the latest therapies and breakthroughs in this field.

There will also be launches of improvised equipments and facilities, together with drug releases by pharmaceutical companies.

The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, role of bio-markers, immunotherapeutics and emerging treatments in the pharmaceutical development pipeline.

The major emphasis will be on the segment of Palliative care and personalized medication along with other aspects of cancer treatment in the 21st century with discussion of significant scientific advances underlying the novel approaches still in preclinical development.

This meeting is an ideal opportunity for oncologists and cancer related health workers to meet and discuss programs which are progressing towards conquering this disease.